Loading...
Target Population: Gastroenterologists
This new evidence-based consensus statement was developed to provide recommendations on the prevention and treatment of venous thromboembolism (VTE) in the specific population of patients with inflammatory bowel disease (IBD).
Hospitalized patients with moderate-to-severe flares without severe bleeding should receive anticoagulant thromboprophylaxis with low-molecular-weight heparin, heparin, or fondaparinux.
Patients hospitalized for indications unrelated to IBD or for IBD with non-severe gastrointestinal bleeding should receive anticoagulant prophylaxis.
Hospitalized patients…